Pharmacological studies of imidazole 2-hydroxybenzoate (ITF 182), an antiinflammatory compound with an action on thromboxane A2 production.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002490:Central Nervous System / Q000187:drug effects; D003645:Death, Sudden / Q000139:chemically induced; D007093:Imidazoles / Q000097:blood; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D051379:Mice; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D012459:Salicylates / Q000097:blood / Q000494:pharmacology* / Q000633:toxicity; D020156:Salicylic Acid; D013276:Stomach Ulcer / Q000139:chemically induced; D013928:Thromboxane A2 / Q000096:biosynthesis*; D013931:Thromboxanes / Q000096:biosynthesis*
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007093:Imidazoles; D012459:Salicylates; D013931:Thromboxanes; C043292:imidazole-2-hydroxybenzoate; D013928:Thromboxane A2; D020156:Salicylic Acid